investors

Investors & analysts

Use alternative, forward looking commercial and scientific impact metrics to capture new investment opportunities and use data to evaluate and predict the performance of listed as well as private life science companies.

medical-affairs

Medical Affairs

Data driven intelligence to help Medical Affairs departments spot earlier scientific trends as well as measure and increase their total scientific impact.

commercial

Commercial Teams

Commercial Conference Share of Voice

Benchmark and learn how to increase your go to market impact.

Data driven intelligence to help commercial departments spot earlier market trends and improve their go-to-market impact.

Homepage Masthead Headline

Sort information from noise and act first on new developments.

Homepage Masthead Subheading

Product Image Carousel

Homepage Testimonial

Homepage

Vaccine capacity and pre-orders

nature

The unequal scramble for coronavirus vaccines — by the numbers

Airfinity are proud to have provided data and analysis for @nature’s latest in-depth piece on vaccine production and distribution, using our world-leading platform to present a clear picture of the current situation.


Researchers at the Serum Institute of India in Pune are manufacturing a COVID-19 vaccine, developed at Oxford University. Credit: Atul Loke/NYT/Redux/eyevine

Airfinity's data and analytics have informed Nature's latest article on the global race for vaccine development and distribution

bloomberg

When It Comes to Covid Shots, Rich Nations Are First in Line

Rush to publish

Airfinity's data and insight have helped inform Bloomberg's latest prognosis on the world scene and vaccine distribution

Scientific conference status - Source: Airfinity data

Figure 1: Scientific conference status

Figure 2: Live presentations and viewers at ACC.20 

 ACC.20 Virtual social engagement Airfinity analysis.

Figure 3: ACC.20 virtual social engagement Airfinity analysis.

Figure 4: Virtual sponsored session, Novartis

Source: Sermo COVID-19 Healthcare Practioner Survey, April 2020.
McKinsey and Co, 2020

Figure 5: HCP expectations of remote-working tools post crisis

What pharma can do to win in virtual

As the life science industry is bracing itself for a prolonged period with minimal in-person meetings, what can the data from the first few months in lockdown tell about how best to navigate this future?

Solutions

Pharmaceutical, Biotech & Medtech

Other

Products

Resources

Company

Life Science’s New Intelligence

Get the full picture in real time

Latest insights & interviews